מיפג'ין

Ülke: İsrail

Dil: İbranice

Kaynak: Ministry of Health

Aktif bileşen:

MIFEPRISTONE

Mevcut itibaren:

A. LAPIDOT PHARMACEUTICALS, LTD

ATC kodu:

G03XB01

Farmasötik formu:

טבליה

Kompozisyon:

MIFEPRISTONE 200 MG

Uygulama yolu:

פומי

Reçete türü:

מרשם נדרש

Tarafından üretildi:

EXELGYNE LABORATORIES, FRANCE

Terapötik grubu:

MIFEPRISTONE

Terapötik alanı:

MIFEPRISTONE

Terapötik endikasyonlar:

Medical alternative to uterine suction for termination of intra-utrerine Pregnancy: - up to and no later than 49 days of amenorrhea (seven weeks) - in sequential use with a prostaglandin analogue misoprostol 400 mcg per os administered 36 to 48 hours after Mifegyne intake. Under these conditions the association of mifepristone and prostaglandins leads to a success rate of about 95 per cent of the cases. Preparation for the action of prostaglandin analogues in the termination of pregnancy for medical reason (beyond the first trimester). Softening and dilatation of the cervix uteri prior to surgical termination of pregnancy during the first trimester.

Yetkilendirme tarihi:

2014-07-31